Correction : Iceland screens, treats, or prevents multiple myeloma (iStopMM): a population-based screening study for monoclonal gammopathy of undetermined significance and randomized controlled trial of follow-up strategies (Blood Cancer Journal, (2021), 11, 5, (94), 10.1038/s41408-021-00480-w)

Útdráttur

In this article the author name Malin Hultcrantz was incorrectly written as Malin Hulcrantz. The original article has been corrected.

Lýsing

Publisher Copyright: © The Author(s) 2023.

Efnisorð

Hematology, Oncology, SDG 3 - Good Health and Well-being

Citation

Rögnvaldsson, S, Löve, Þ J, Þorsteinsdóttir, S, Reed, E R, Óskarsson, J Þ, Pétursdóttir, Í, Sigurðardóttir, G Á, Viðarsson, B, Önundarson, P T, Agnarsson, B A, Sigurðardóttir, M, Þorsteinsdóttir, I, Ólafsson, Í, Þórðardóttir, Á R, Eyþórsson, E S, Jónsson, Á, Björnsson, A S, Gunnarsson, G Þ, Pálsson, R, Indriðason, Ó S, Gíslason, G K, Ólafsson, A, Hákonardóttir, G K, Brinkhuis, M, Halldórsdóttir, S L, Ásgeirsdóttir, T L, Steingrímsdóttir, H, Danielsen, R, Wessman, I D, Kampanis, P, Hultcrantz, M, Durie, B G M, Harding, S, Landgren, O & Kristinsson, S Y 2023, 'Correction : Iceland screens, treats, or prevents multiple myeloma (iStopMM): a population-based screening study for monoclonal gammopathy of undetermined significance and randomized controlled trial of follow-up strategies (Blood Cancer Journal, (2021), 11, 5, (94), 10.1038/s41408-021-00480-w)', Blood Cancer Journal, vol. 13, no. 1, 39, pp. 39. https://doi.org/10.1038/s41408-023-00814-w

Undirflokkur